You are here

  • Home
  • Archive
  • Volume 30, Issue 6
  • Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

Citation Tools

Article menu
Download PDFPDF
Clinical trial
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Koole S, van Stein R, Sikorska K on behalf of the OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group, et al
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial
International Journal of Gynecologic Cancer 2020;30:888-892.